Current guidelines for Covid-19 and people living with HIV/AIDS-A Review
Abstract
There is an extraordinary worry about the effect of COVID-19 (Corona virus disease-2019) among the almost 40 million people living with HIV (PLWH) around the world. Having HIV (Human immune deficiency virus) doesn’t present assurance against serious appearances of COVID-19. A few drug trials/investigations looking at antiretroviral drugs against HIV to treat SARS-CoV-2 have shown no mortality advantage. Subsequently, there is no sign to change antiretroviral treatment (ART) regimens among virologically stifled PLWH to forestall COVID-19. HIV care services have been unfavorably affected in a few nations during this pandemic yet has set out a freedom for speeding up successful techniques like dispensing multi-month ART. Decentralizing HIV care in low-asset settings and fusing telemedicine in high-asset settings will be basic in moderating stuns to medical care frameworks later on.
References
National Center for Immunization and Respiratory Diseases (NCIRD). (2021, Feb) Division of
Viral Diseases, What to Know About HIV and COVID-19. [Online] Available from
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/hiv.html
HIV.gov. (2021,Feb) Guidance for COVID-19 and People with HIV. [Online] Available from
Dotters-Katz S, Hughes BL.(2020) Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal
Medicine Subspecialists Need to Know. [Online] Available from
https://s3.amazonaws.com/cdn.smfm.org/media/2267/COVID19-_updated_3-17-20_PDF.pdf.
Liu Y, Chen H, et al. Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection
during pregnancy. J Infect. 2020; S0163-4453(20)30109-2.
Chen H, Guo J, et al. Clinical characteristics and intrauterine vertical transmission potential of
COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet.
; 395(10226):809-815.
Siston AM, Rasmussen SA, et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant
women in the United States. JAMA. 2010;303(15):1517-1525.
Alfaraj SH, Al-Tawfiq JA, et al. Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol
Infect. 2019;52(3):501-503.
Wong SF, Chow KM, et al. Pregnancy and perinatal outcomes of women with severe acute
respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292-297.
Wang D, Hu B, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.
Wang S, Guo L, Chen L, et al. A Case Report of Neonatal 2019 Coronavirus Disease in China.
Clin. Infect Dis. 2020; 71(15):853-857.
Dong Y, Mo X, et al. Epidemiology of COVID-19 among Children in China. Pediatrics.
;145(6):20200702.
Cruz AT, Zeichner SL. COVID-19 in Children: Initial Characterization of the Pediatric Disease.
Pediatrics. 2020;145(6):20200834.
Shen K, Yang Y, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in
children: experts' consensus statement. World J Pediatr. 2020;16(3):223-231.
Ogimi C, Englund JA, et al. Characteristics and outcomes of coronavirus infection in children: The
role of viral factors and an immunocompromised state. J Pediatric Infect Dis Soc. 2019; 8(1):21-
UNAIDS | (2020) What people living with HIV need to know about HIV and COVID-19. [online]
Available from https://www.unaids.org/sites/default/files/media_asset/HIV_COVID19_brochure_en.pdf
